What's Happening?
NASA, through its Translational Research Institute for Space Health (TRISH), is inviting proposals to study venous thromboembolism (VTE) in space. VTE, which involves the formation of blood clots in veins, poses a significant health risk during spaceflight.
The mechanisms behind VTE in microgravity are not well understood, and current preventive measures are limited. The research aims to explore the pathophysiology of VTE in space and develop ground-based analogs to simulate these conditions. This initiative is part of NASA's efforts to address health challenges associated with human space exploration. Proposals are open to U.S. institutions and companies, with a funding cap of $500,000 per project. The deadline for submissions is August 18, 2026.
Why It's Important?
Understanding and mitigating the risks of VTE in space is crucial for the safety of astronauts on long-duration missions. As NASA plans for future exploration missions, including potential trips to Mars, addressing health risks like VTE becomes increasingly important. Successful research could lead to the development of effective countermeasures, ensuring the health and safety of crew members. This initiative also highlights the broader implications of space health research, which can contribute to medical advancements on Earth, particularly in understanding and treating blood clot-related conditions.
What's Next?
Following the proposal submission deadline, selected projects will undergo a research period of up to 15 months. The outcomes of these studies could inform the development of new health protocols for space missions. Additionally, the findings may influence future NASA policies and strategies for managing health risks in space. The collaboration between NASA, academic institutions, and private companies is expected to foster innovation and accelerate the development of solutions for space health challenges.
